HOME >> MEDICINE >> NEWS
Research Offers New Tool In Fight Against Prostate Cancer

ANN ARBOR---Research from the University of Michigan Comprehensive Cancer Center strongly suggests that PSA tests can reliably gauge the effectiveness of chemotherapy for advanced prostate cancer.

A reliable method of assessing a cancer patient's response to treatment is important. It shows doctors whether the prescribed therapy is working and allows them to quickly and confidently change the treatment plan when it's ineffective---and presumably improve the patient's quality of life as a result.

The U-M researchers studied 62 men with advanced prostate cancer and found that those whose PSA level declined 50 percent or more after eight weeks of chemotherapy had a significantly higher survival rate.

PSA screening tests are used to measure the level of a prostate-specific antigen in the blood---which indicates the presence of prostate cancer. They also have been used to gauge patients' response to cancer therapy, but that application has been controversial because opinions differ on its validity and precisely how to interpret test results.

The U-M researchers found that patients whose PSA levels declined at least 50 percent after eight weeks of chemotherapy survived for 91 weeks (median), compared with 38 weeks for those whose PSA level did not decline 50 percent.

The study is detailed in the May issue of the Journal of Clinical Oncology. It was conducted by David C. Smith, M.D.; Kenneth J. Pienta, M.D.; Rodney L. Dunn, M.S.; and Myla S. Strawderman, M.S.


'"/>

Contact: David Wilkins
wilkins@umich.edu
(734) 764-2220
University of Michigan
30-Apr-1998


Page: 1

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Research Offers New Tool Fight Against Prostate Cancer

(Date:3/5/2015)... 2015 This week, 60 ... low-cost laminate flooring products, initiating widespread concern from ... building materials made primarily from bamboo, stands behind ... their flooring products for volatile organic compounds (VOCs) ... International (BMH). Results from formaldehyde emissions testing ...
(Date:3/5/2015)... Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ) ... tort litigation currently underway in the Philadelphia Court ... hearing testimony in the proceeding’s second bellwether trial ... cause gynecomastia, or male breast growth. According to ... on behalf of a plaintiff who was prescribed ...
(Date:3/5/2015)... 2015 Rhode Island Medical Imaging (RIMI) was ... row to support the Providence College (PC) women’s basketball program’s ... purchase of the ‘Think Pink’ uniforms, which were worn during ... opponent DePaul University at Alumni Hall/Mullaney Gymnasium in Providence, R.I. ... of the PC women’s basketball’s ‘Pink Out’ event,” said Dr. ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 On March ... “Butt Augmentation, Labiaplasty on the Rise, Plastic Surgeons Say,” ... the American Society for Aesthetic Plastic Surgery ... Both groups reported a year-over-year doubling of surgical butt ... physicians quoted in the article, this increase can be ...
(Date:3/5/2015)... TCS Healthcare Technologies (TCS), a leading provider ... management arena, is pleased to announce a webinar focusing ... Care™ (ACUITY) version 7.20. The session will focus on ... of automation. , The webinar, scheduled for March 18, ... Jeff Frater, RN, BSN, Director of Partner Development at ...
Breaking Medicine News(10 mins):Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3
(Date:3/5/2015)... 05, 2015 Research and Markets ( ... "India Pharma Outlook 2015: Accelerating growth to the next ... report to their offering. Domestic ... the 2013 caused by the market,s reaction to the ... to continue to be healthy, as the momentum continues ...
(Date:3/5/2015)... and HAMPTON, N.J. , March 5, ... MNK ), a leading global specialty biopharmaceutical company, ... today that they have entered into a definitive agreement ... Inc. from a Madison Dearborn -led investor group ... Subject to customary closing conditions, the parties ...
(Date:3/5/2015)... -- According to a new market research ... Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User ... - Analysis & Global Forecast to 2019" , the ... $1,107.4 Million by 2019 from $887.8 Million in 2014, ... 4.5% during the forecast period. Browse ...
Breaking Medicine Technology:India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
Cached News: